Ben Tre Pharmaceutical JSC (HOSE:DBT)

Market Cap	227.36B +1.0%
Revenue (ttm)	860.40B -0.9%
Net Income	14.03B -3.7%
EPS	638.88 -11.5%
Shares Out	21.97M
PE Ratio	16.20
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,207
Average Volume	11,505
Open	10,300
Previous Close	10,250
Day's Range	10,300 - 10,350
52-Week Range	9,907 - 12,150
Beta	0.53
RSI	32.65
Earnings Date	Feb 3, 2026

About HOSE:DBT

Ben Tre Pharmaceutical Joint Stock Company manufactures, distributes, and sells pharmaceutical products in Vietnam and internationally. The company offers drugs in injectable, infusion, pill, and lotion forms. The company provides products covering various therapeutic areas, including central nervous system, respiratory system, endocrinology, obstetrics and gynecology, anti-allergic, cardiovascular, antibiotics, anti-fungal, anti-viral, musculoskeletal, vitamins and minerals, digestive, hepatobiliary and urinary, pain relief, fever reducer, ant...

• Industry: Pharmaceutical Preparations
• Founded: 1963
• Employees: 781
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DBT

Financial Performance

In 2025, HOSE:DBT's revenue was 860.40 billion, a decrease of -0.92% compared to the previous year's 868.41 billion. Earnings were 14.03 billion, an increase of 4.07%.